University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”

Simple item page
dc.contributor.authorBruhn, Hanne
dc.contributor.authorAnderson, Annie S.
dc.contributor.authorHickman, Amy
dc.contributor.authorMacaskill, E. Jane
dc.contributor.authorTreweek, Shaun
dc.contributor.institutionUniversity of Aberdeen.Psychologyen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Evaluationen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2021-06-07T13:58:01Z
dc.date.available2021-06-07T13:58:01Z
dc.date.issued2021-06-05
dc.descriptionAcknowledgements We would like to thank our ActWELL participants who attended the events for their interest and enthusiasm in making the events a success. We would like to thank Susan MacAskill for giving us permission to use a quote from her email to us. We are also grateful to the technical support who got us through all events, Cormac Staunton (of stauntonmedia.ie). We would also like to acknowledge and thank Dr Katie Gillies and Dr Seonaidh Cotton for their contribution to the design of the evaluation survey. HSRU is core funded by the Chief Scientist Office of the Scottish Government Health and Social Care Directorates. This work was supported by The Scottish Government, grant number BC/ Screening/17/01.en
dc.description.statusPeer revieweden
dc.format.extent5
dc.format.extent507327
dc.identifier194726132
dc.identifier1e6e4989-cecd-4412-b371-e28fcab2029f
dc.identifier85107203204
dc.identifier.citationBruhn, H, Anderson, A S, Hickman, A, Macaskill, E J & Treweek, S 2021, 'Letter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”', Trials, vol. 22, no. 1, 381. https://doi.org/10.1186/s13063-021-05340-3en
dc.identifier.doi10.1186/s13063-021-05340-3
dc.identifier.iss1en
dc.identifier.issn1745-6215
dc.identifier.otherRIS: urn:01533BB382B5B86422E91AB5EDFB7135
dc.identifier.otherRIS: Bruhn2021
dc.identifier.otherORCID: /0000-0002-7239-7241/work/186968505
dc.identifier.urihttps://hdl.handle.net/2164/16642
dc.identifier.vol22en
dc.language.isoeng
dc.relation.ispartofTrialsen
dc.subjectRandomised trialsen
dc.subjectResearch transparencyen
dc.subjectResult disseminationen
dc.subjectTrial conducten
dc.subjectOnline eventsen
dc.subjectCOVID-19en
dc.subjectR Medicineen
dc.subjectOtheren
dc.subjectBC/ Screening/17/01en
dc.subject.lccRen
dc.titleLetter on “Sharing trial results directly with trial participants and other stakeholders after the SARS-CoV-2 pandemic hit the UK – experience from the ActWELL trial”en
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Bruhn_etal_TRIALS_Letter_On_Sharing_VoR.pdf
Size:
495.44 KB
Format:
Adobe Portable Document Format
Download

Collections

All research